Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Vir Biotechnology Inc (NQ: VIR ) 7.830 -0.150 (-1.88%) Streaming Delayed Price Updated: 4:00 PM EDT, Sep 11, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Vir Biotechnology Inc < Previous 1 2 3 4 5 6 7 8 9 ... 12 13 Next > Assessing Vir Biotechnology: Insights From 5 Financial Analysts March 15, 2024 Via Benzinga Billionaire’s Biotech Bets: 3 Stocks Dominating Bill Gates’ Portfolio March 13, 2024 One of the primary features of Bill Gates biotech stocks is they are all working towards a cure for HIV and related illnesses. Via InvestorPlace Vir Biotechnology Completes Enrollment of Phase 2 Chronic Hepatitis Delta SOLSTICE Trial Ahead of Schedule March 05, 2024 From Vir Biotechnology, Inc. Via Business Wire 3 Highly Rated Biotech Stocks to Buy for 300% Gains February 26, 2024 Biotech stocks like those discussed here have the potential to produce 300% returns and benefit from high analyst ratings. Via InvestorPlace Recap: Vir Biotechnology Q4 Earnings February 22, 2024 Via Benzinga Earnings Outlook For Vir Biotechnology February 21, 2024 Via Benzinga JP Morgan Downgrades Vir Biotechnology: Here's What You Need To Know January 29, 2024 Via Benzinga Why MercadoLibre Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session February 23, 2024 Shares of MercadoLibre, Inc. (NASDAQ: MELI) fell sharply during Friday’s session after the company reported fourth-quarter financial results. Via Benzinga Carvana Posts Q4 Results, Joins LegalZoom.com, Comfort Systems And Other Big Stocks Moving Higher On Friday February 23, 2024 U.S. stocks were mostly higher, with the Dow Jones index gaining more than 100 points on Friday. Via Benzinga Topics Stocks Exposures US Equities Vir Biotechnology to Participate in Upcoming Investor Healthcare Conferences February 23, 2024 From Vir Biotechnology, Inc. Via Business Wire Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results February 22, 2024 From Vir Biotechnology, Inc. Via Business Wire Vir Biotechnology Announces Dr. Phil Pang Will Step Down as Chief Medical Officer February 20, 2024 From Vir Biotechnology, Inc. Via Business Wire 3 Hidden-Gem Biotech Stocks Ready to Ride a Massive Market Wave February 14, 2024 Explore hidden-gem biotech stocks set for growth in a booming market. Uncover top picks ready to redefine healthcare innovation. Via InvestorPlace Earnings Scheduled For February 22, 2024 February 22, 2024 Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on revenue of $260.00 million. Via Benzinga Vir Biotechnology to Provide Business Update and Report Fourth Quarter 2023 Financial Results on February 22, 2024 February 01, 2024 From Vir Biotechnology, Inc. Via Business Wire HC Wainwright & Co. Maintains Buy Rating for Vir Biotechnology: Here's What You Need To Know January 23, 2024 Via Benzinga COVAX Global Initiative For COVID-19 Vaccines Comes To An End Amid Shift To Regular Programs December 20, 2023 COVAX, the multilateral mechanism for equitable global access to COVID-19 vaccines launched in 2020, will close on 31 December 2023.&n Via Benzinga Exposures COVID-19 Vir Biotechnology Announces Strategic Steps to Reduce Operating Expenses and Focus Investment on Areas with Highest Potential for Value Creation December 13, 2023 From Vir Biotechnology, Inc. Via Business Wire Vir Biotechnology to Present at J.P. Morgan 2024 42nd Annual Healthcare Conference December 06, 2023 From Vir Biotechnology, Inc. Via Business Wire 7 Small-Cap Stocks to Buy BEFORE the Year-End Rally November 30, 2023 explore and wager on these top small-cap stocks to buy, poised for significant gains in today's dynamic global economy Via InvestorPlace From laggards to leaders: Small caps on the rise November 27, 2023 Despite large-cap dominance, signs suggest a shift to small-cap leadership. Valuations, positive Q3 results, and historical patterns point to potential gains. Via MarketBeat Vir Biotechnology to Present New Data from Its Ongoing Phase 2 Chronic Hepatitis Delta and B Trials Today at AASLD’s The Liver Meeting® 2023 November 13, 2023 From Vir Biotechnology, Inc. Via Business Wire Vir Biotechnology to Present Late-Breaking Data from Its Ongoing Phase 2 Chronic Hepatitis B and Delta Trials at AASLD’s The Liver Meeting® 2023 November 10, 2023 From Vir Biotechnology, Inc. Via Business Wire Vir Biotechnology Ranked the Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500™ November 08, 2023 From Vir Biotechnology, Inc. Via Business Wire Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2023 Financial Results November 02, 2023 From Vir Biotechnology, Inc. Via Business Wire Earnings Scheduled For November 2, 2023 November 02, 2023 Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly earnings at $0.18 per share on revenue of $61.52 million. Via Benzinga Vir Biotechnology Appoints Jennifer Towne, Ph.D., as Executive Vice President and Chief Scientific Officer October 30, 2023 From Vir Biotechnology, Inc. Via Business Wire 3 Bill Gates Stocks to Buy for Billionaire-Like Returns October 27, 2023 Microsoft and Berkshire Hathaway are the two most popular Bill Gates stocks. Investors know these three others far less. Via InvestorPlace 7 Biotech Stocks to Get In Now Before Investors Catch On October 23, 2023 Biotech stocks are down, but there are hidden gems among the rubble. Get in now before the broader market finds them. Via InvestorPlace Vir Biotechnology to Participate in the H.C. Wainwright 4th Annual Hepatitis B Virus (HBV) Conference October 12, 2023 From Vir Biotechnology, Inc. Via GlobeNewswire < Previous 1 2 3 4 5 6 7 8 9 ... 12 13 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.